About t2 biosystems - TTOO
T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
TTOO At a Glance
T2 Biosystems, Inc.
101 Hartwell Avenue
Lexington, Massachusetts 02421
| Phone | 1-781-761-4646 | Revenue | 7.19M | |
| Industry | Medical Specialties | Net Income | -50,077,000.00 | |
| Sector | Health Technology | Employees | 113 | |
| Fiscal Year-end | 12 / 2024 | |||
| View SEC Filings |
TTOO Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.277 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.084 |
| Enterprise Value to Sales | 6.977 |
| Total Debt to Enterprise Value | 0.986 |
TTOO Efficiency
| Revenue/Employee | 63,654.867 |
| Income Per Employee | -443,159.292 |
| Receivables Turnover | 5.065 |
| Total Asset Turnover | 0.208 |
TTOO Liquidity
| Current Ratio | 0.447 |
| Quick Ratio | 0.361 |
| Cash Ratio | 0.279 |
TTOO Profitability
| Gross Margin | -122.744 |
| Operating Margin | -655.54 |
| Pretax Margin | -696.191 |
| Net Margin | -696.191 |
| Return on Assets | -144.89 |
| Return on Equity | N/A |
| Return on Total Capital | -233.329 |
| Return on Invested Capital | N/A |
TTOO Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 230.631 |
| Total Debt to Total Assets | 142.248 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 30.743 |